Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Liposomal drug delivery systems for the treatment of leishmaniasis
Felipe Francisco Tuon, Letícia Ramos Dantas, Regina Maia de Souza, et al.
Parasitology Research (2022) Vol. 121, Iss. 11, pp. 3073-3082
Closed Access | Times Cited: 19

Showing 19 citing articles:

Is leishmaniasis the new emerging zoonosis in the world?
Esperanza Montaner-Angoiti, Lola Llobat
Veterinary Research Communications (2023) Vol. 47, Iss. 4, pp. 1777-1799
Closed Access | Times Cited: 29
Curcumin-loaded nanostructured systems for treatment of leishmaniasis: a review
Douglas Dourado, Thayse Silva Medeiros, Éverton N. Alencar, et al.
Beilstein Journal of Nanotechnology (2024) Vol. 15, pp. 37-50
Open Access | Times Cited: 7
Evaluation the biological effect of niosomal hydrogel base amphotericin in combination with Artemisia sieberi essential oil for treatment of cutaneous leishmaniasis: In vitro and in vivo studies
Hanieh Ardeshiri, Amir Hossein Radfar, Gholamreza Hatam, et al.
Results in Chemistry (2025), pp. 102185-102185
Open Access
In Vitro Evaluation of Aerosol Therapy with Pentamidine-Loaded Liposomes Coated with Chondroitin Sulfate or Heparin for the Treatment of Leishmaniasis
Lucía Román-Álamo, Mohamad Allaw, Yunuen Ávalos-Padilla, et al.
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1163-1163
Open Access | Times Cited: 9
Revolutionizing Leishmaniasis Treatment with Cutting Edge Drug Delivery Systems and Nanovaccines: An Updated Review
Srushti Tambe, Sagnik Nag, Shivani R. Pandya, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 6, pp. 1871-1889
Closed Access | Times Cited: 3
The Nexus between Leishmania & HIV: Debilitating Host Immunity and Hastening Comorbid Disease Burden
Manasvi Dhulipalla, Garima Chouhan
Experimental Parasitology (2024) Vol. 265, pp. 108826-108826
Closed Access | Times Cited: 3
Review of Novel Oral Amphotericin B Formulations for the Treatment of Parasitic Infections
Ellen K. Wasan, Tavonga T. Mandava, Pablo Crespo-Moran, et al.
Pharmaceutics (2022) Vol. 14, Iss. 11, pp. 2316-2316
Open Access | Times Cited: 14
In vitro evaluation of antileishmanial activity of Boswellia serrata essential oil nanoliposome
Mohaddeseh Babaei, Mohammad Reza Youssefi, Nadia Taiefi Nasrabadi
Veterinary Medicine and Science (2024) Vol. 10, Iss. 2
Open Access | Times Cited: 2
Rational repurposing, synthesis, in vitro and in silico studies of chromone-peptidyl hybrids as potential agents against Leishmania donovani
Ahmed H.E. Hassan, Waleed A. Bayoumi, Selwan M. El‐Sayed, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 5
Can amphotericin B and itraconazole be co-delivered orally? Tailoring oral fixed-dose combination coated granules for systemic mycoses
Raquel Fernández-García, D. Walsh, P. O’Connell, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2023) Vol. 183, pp. 74-91
Open Access | Times Cited: 4
Design, Synthesis, and Repurposing of Rosmarinic Acid-β-Amino-α-Ketoamide Hybrids as Antileishmanial Agents
Ahmed H.E. Hassan, Waleed A. Bayoumi, Selwan M. El‐Sayed, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 11, pp. 1594-1594
Open Access | Times Cited: 4
A novel outlook in the delivery of artemisinin: production and efficacy in experimental visceral leishmaniasis
Maryam Akbari, H. Heli, Ahmad Oryan, et al.
Pathogens and Global Health (2023) Vol. 118, Iss. 1, pp. 40-46
Closed Access | Times Cited: 3
31st Annual GP2A Medicinal Chemistry Conference
Nicolas Primas, Caroline Castera‐Ducros, Romain Paoli-Lombardo, et al.
Drugs and Drug Candidates (2024) Vol. 3, Iss. 1, pp. 209-243
Open Access
The Concurrence of Visceral Leishmaniasis and Acquired Immunodeficiency Syndrome: Current Impact and Challenges
Manasvi Dhulipalla, Garima Chouhan
(2024)
Closed Access
Molecular and Immunological Properties of a Chimeric Glycosyl Hydrolase 18 Based on Immunoinformatics Approaches: A Design of a New Anti-Leishmania Vaccine
José Ednésio da Cruz Freire, André Nogueira Cardeal dos Santos, Andrelina Noronha Coelho‐de‐Souza, et al.
ACS Pharmacology & Translational Science (2024) Vol. 8, Iss. 1, pp. 78-96
Open Access
The Prospects of Phytomedicines and Nanomedicines to Treat Leishmaniasis: A Comprehensive Review
Rajan Swami, Keshav Aggarwal
Current Drug Research Reviews (2023) Vol. 16, Iss. 3, pp. 308-318
Closed Access | Times Cited: 1
Ericaria amentacea Algae Extracts: A Sustainable Approach for the Green Synthesis of Silver Oxide Nanoparticles and Their Effectiveness against Leishmaniasis
Fatouma Mohamed Abdoul‐Latif, Ayoub Ainane, Ibrahim Houmed Aboubaker, et al.
Processes (2023) Vol. 11, Iss. 11, pp. 3227-3227
Open Access | Times Cited: 1
Design, development and formulation of Miltefosine loaded Mannosylated Liposomes for Anti-leishmanial activity
Shubham Chourasiya, Mansha Singhai, Sunil Jain, et al.
Advance Pharmaceutical Journal (2023) Vol. 8, Iss. 3, pp. 66-70
Open Access
Advances in Antileishmanial Chemotherapy
Shaikh Shuhail, Saswata Das, Tirtharaj Datta, et al.
(2023), pp. 245-302
Closed Access
Page 1

Scroll to top